AEHR · available-data snapshot
Aehr Test Systems, Inc. (AEHR): Available-Data Snapshot
TickerWorth does not publish a DCF fair value for Aehr Test Systems, Inc. (AEHR); the reason is set out below. What its filings and market data do show is below. The snapshot also sets out its trading multiples against 5 peers. Snapshot as of Oct 19, 2026.
Model by Miraaj Patel · generated from public market data · Updated Oct 19, 2026 · How these pages are made
Why is there no fair value for AEHR?
We do not publish a fair value for Aehr Test Systems, Inc.. What we can say from its filings and market data is below.
What is AEHR's TickerWorth Score?
Scores lower than almost every company we compare it with
Compared with Technology companies in US
Its strongest point: growing quickly. Its weakest: looks expensive on the numbers.
- Value · 17 of 100
Cheaper than 17% of Technology companies in US
- Price vs worth · 0 of 100
- Quality · 17 of 100
More profitable than 17% of Technology companies in US
- Financial health · 65 of 100
Financially stronger than 65% of Technology companies in US
- Growth · 70 of 100
Growing faster than 70% of Technology companies in US
- Momentum · 57 of 100
Outperformed 57% of Technology companies in US over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
- Price
- $65.36
- Market cap
- $2,
134, 464, 768 - 52-week high
- $147.40
- 52-week low
- $18.70
- Currency
- USD
- Exchange
- NasdaqCM
Snapshot of Oct 19, 2026, quote time not published · Prices are delayed.
What we can say
We don't publish a discounted-cash-flow fair value for Aehr Test Systems, Inc. (AEHR) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.
Read the full reasoning
On the numbers we do have, AEHR trades at a recent price of $65.36, a market capitalisation of about $2,134,464,768, sitting 36% of the way up its 52-week range ($18.70–$147.40), on the NasdaqCM.
The standard alternative to a DCF is relative valuation — comparing AEHR's trading multiples against a sector benchmark. Here that gives Fwd P/E of 47.2× (richer than the peer median of 17.3×); P/B of 9.7× (cheaper than the peer median of 16.1×); P/S of 42.7× (richer than the peer median of 11.9×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. AEHR shows a price-to-book (P/B) of 9.67 and book value of $6.76 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.
Finally, a price-based read — explicitly not a valuation. AEHR is in a mixed trend, trading -55.7% from its 52-week high. Over the past year the stock is +110.4%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
AEHR vs peers
Sector benchmark (bellwethers, not direct competitors).
| Multiple | AEHR | Peer median | Read |
|---|---|---|---|
| Fwd P/E | 47.2× | 17.3× | richer than |
| P/B | 9.7× | 16.1× | cheaper than |
| P/S | 42.7× | 11.9× | richer than |
What does Aehr Test Systems, Inc. do?
What does it do?
Aehr Test Systems, Inc. provides test solutions for testing, burn-in, and semiconductor devices at wafer level, singulated die, and package level in the United States, Asia, Europe, and the Middle East. It operates in the Semiconductor Equipment & Materials industry (Technology sector), headquartered in United States. The company employs roughly 138 people.
How does it make money?
The business turns $50M in annual revenue into profit. Out of every $100 of sales, about $0 is left as operating profit (operating margin of -6.4%), after a 35% gross margin on the products/services it sells. After all costs, taxes and interest, -14.3% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks mixed: carries heavy debt (4.5× equity), comfortably covers its short-term bills (10.3× current ratio), and is currently lossmaking.
Who at AEHR filed insider trades?
| Date | Insider | Relationship | What happened | Value | Filing |
|---|---|---|---|---|---|
| Siu Chris | CFO | Shares withheld (tax) | $83,539.68 | Form 4 for Siu Chris (opens sec.gov in a new tab) | |
| SPORCK ALISTAIR N | VP Contactor Business Unit | Shares withheld (tax) | $24,968.80 | Form 4 for SPORCK ALISTAIR N (opens sec.gov in a new tab) | |
| ROGERS VERNON | Exec VP of Sales & Mktg. | Shares withheld (tax) | $36,056.64 | Form 4 for ROGERS VERNON (opens sec.gov in a new tab) | |
| RICHMOND DONALD P. II | CTO | Shares withheld (tax) | $32,840.32 | Form 4 for RICHMOND DONALD P. II (opens sec.gov in a new tab) | |
| ENGINEER ADIL | Chief Operating Officer | Shares withheld (tax) | $46,298.08 | Form 4 for ENGINEER ADIL (opens sec.gov in a new tab) | |
| Erickson Gayn | Director, President and CEO | Shares withheld (tax) | $226,412.00 | Form 4 for Erickson Gayn (opens sec.gov in a new tab) |
A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans
Companies we do put a number on
Not investment advice. TickerWorth Score is a model output.
A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public market data that can be wrong, stale or incomplete.